Boston Globe LTE: Double standard over weight loss drugs hits women especially hard
July 20, 2026
In response to an opinion piece in the Boston Globe on how Massachusetts insurers are dropping coverage of GLP-1 medications, Millicent Gorham, CEO of EveryBODY Covered convenor the Alliance for Women’s Health & Prevention, points out the double standard of how obesity treatments are evaluated compared to other chronic diseases and the serious consequences for women.
Read the full letter here.